Behzad Amoozgar

发表

Tafasitamab and Lenalidomide in Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL): Real World Outcomes in a Multicenter Retrospective Study

V. Seshan, P. Caimi, M. Okwali, 2022, Blood.